Skip to main content
Clinical Trials/DRKS00016683
DRKS00016683
Recruiting
未知

Transarterial, interventional radiological Treatment of hemorrhoidal disease - EMBORRHOID-MUC

Klinikum der Universität München, Campus Großhadern0 sites30 target enrollmentMarch 13, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
K64
Sponsor
Klinikum der Universität München, Campus Großhadern
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 13, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinikum der Universität München, Campus Großhadern

Eligibility Criteria

Inclusion Criteria

  • Patients with symptomatic internal hemorrhoids 2nd / 3rd degree, lack of response to prior therapies (conservative basic treatment, medication, endoscopic procedures, minimally invasive procedures, contraindication to surgery and failed surgical/endoscopic treatment, negative colonoscopic correlation (during the past 24 months), no existing promising alternative endovascular/surgical therapeutic option, platelet count \= 50\.000 / µl, PTT \< 50 s, INR \< 1,5, age\-adjusted normal serum creatinine or creatinine clearance \= 30 ml/min / 1,73 m² for safe application of contrast media.

Exclusion Criteria

  • feasible surgical or endoscopic treatment, hemorrhoidal disease 1st and 4th degree, fixed prolaps, absent access via superior mesenteric artery (e.g. after hemicolectomy), after rectal resection, after endovascular aortic repair (EVAR), acute diseases like fissures, infections, abscesses etc., anatomic contraindications: stenoses, fistula, vascular occlusions, prior colorectal surgery, colorectal anomalies, allergic reactions to contrast media, severe kidney failure, pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials